Ausgabe 3/2010
Inhalt (29 Artikel)
At last, a predictive and prognostic marker for radiotherapy?
Philip Coates, John Dewar, Alastair M Thompson
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
Johan Staaf, Göran Jönsson, Markus Ringnér, Johan Vallon-Christersson, Dorthe Grabau, Adalgeir Arason, Haukur Gunnarsson, Bjarni A Agnarsson, Per-Olof Malmström, Oskar Th Johannsson, Niklas Loman, Rosa B Barkardottir, Åke Borg
Cyclophosphamide- metabolizing enzyme polymorphisms and survival outcomes after adjuvant chemotherapy for node-positive breast cancer: a retrospective cohort study
Priya P Gor, H Irene Su, Robert J Gray, Phyllis A Gimotty, Michelle Horn, Richard Aplenc, William P Vaughan, Martin S Tallman, Timothy R Rebbeck, Angela DeMichele
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells
Luisa Paris, Serena Cecchetti, Francesca Spadaro, Laura Abalsamo, Luana Lugini, Maria Elena Pisanu, Egidio Iorio, Pier Giorgio Natali, Carlo Ramoni, Franca Podo
Incorporating tumour pathology information into breast cancer risk prediction algorithms
Nasim Mavaddat, Timothy R Rebbeck, Sunil R Lakhani, Douglas F Easton, Antonis C Antoniou
Tumour-associated carbohydrate antigens in breast cancer
Aurélie Cazet, Sylvain Julien, Marie Bobowski, Joy Burchell, Philippe Delannoy
The contribution of dynamic stromal remodeling during mammary development to breast carcinogenesis
Jessica McCready, Lisa M Arendt, Jenny A Rudnick, Charlotte Kuperwasser
Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors
Liat Goldshaid, Efrat Rubinstein, Alexander Brandis, Dadi Segal, Noa Leshem, Ori Brenner, Vyacheslav Kalchenko, Doron Eren, Tamar Yecheskel, Yoseph Salitra, Yoram Salomon, Avigdor Scherz
Just when you thought it was safe to go into the membrane: the growing complexities of extra-nuclear progesterone signaling
Aritro Sen, Stephen R Hammes
Breast cancer-specific mutations in CK1ε inhibit Wnt/β-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration
Silvie Foldynová-Trantírková, Petra Sekyrová, Kateřina Tmejová, Eva Brumovská, Ondřej Bernatík, Wulf Blankenfeldt, Pavel Krejčí, Alois Kozubík, Tomáš Doležal, Lukáš Trantírek, Vítězslav Bryja
Association between the spread of circulating tumor cells and breast cancer subtypes
Xiaowei Qi, Xinhua Yang, Linjun Fan, Yi Zhang, Fan Zhang, Jun Jiang
Senescence evasion by MCF-7 human breast tumor-initiating cells
Feridoun Karimi-Busheri, Aghdass Rasouli-Nia, John R Mackey, Michael Weinfeld
Key signalling nodes in mammary gland development and cancer. The Snail1-Twist1 conspiracy in malignant breast cancer progression
Ellen Foubert, Bram De Craene, Geert Berx
Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-α and survivin
Kathryn E Vanderlaag, Susan Hudak, Laura Bald, Laurence Fayadat-Dilman, Manjiri Sathe, Jeff Grein, Mary J Janatpour
Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women
Ada Tosovic, Anne-Greth Bondeson, Lennart Bondeson, Ulla-Britt Ericsson, Johan Malm, Jonas Manjer
Progesterone reverses the mesenchymal phenotypes of basal phenotype breast cancer cells via a membrane progesterone receptor mediated pathway
Lian Zuo, Wei Li, Shaojin You
Pregnancy-related factors and the risk of breast carcinoma in situand invasive breast cancer among postmenopausal women in the California Teachers Study cohort
Huiyan Ma, Katherine D Henderson, Jane Sullivan-Halley, Lei Duan, Sarah F Marshall, Giske Ursin, Pamela L Horn-Ross, Joan Largent, Dennis M Deapen, James V Lacey Jr, Leslie Bernstein
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns
Karolina Holm, Cecilia Hegardt, Johan Staaf, Johan Vallon-Christersson, Göran Jönsson, Håkan Olsson, Åke Borg, Markus Ringnér
The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET
Michal E Schneider-Kolsky, Stewart Hart, Jane Fox, Peter Midolo, John Stuckey, Michael Hofman, Vinod Ganju
Cooperative signaling between Wnt1 and integrin-linked kinase induces accelerated breast tumor development
Arusha Oloumi, Mykola Maidan, Frances E Lock, Howard Tearle, Steven McKinney, William J Muller, Samuel AJR Aparicio, Shoukat Dedhar
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer
Karen J Taylor, Andrew H Sims, Liang Liang, Dana Faratian, Morwenna Muir, Graeme Walker, Barbara Kuske, J Michael Dixon, David A Cameron, David J Harrison, Simon P Langdon
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
Chad J Creighton, Xiaoyong Fu, Bryan T Hennessy, Angelo J Casa, Yiqun Zhang, Ana Maria Gonzalez-Angulo, Ana Lluch, Joe W Gray, Powell H Brown, Susan G Hilsenbeck, C Kent Osborne, Gordon B Mills, Adrian V Lee, Rachel Schiff
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
Joshua A Bauer, Fei Ye, Clayton B Marshall, Brian D Lehmann, Christopher S Pendleton, Yu Shyr, Carlos L Arteaga, Jennifer A Pietenpol
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
Göran Jönsson, Johan Staaf, Johan Vallon-Christersson, Markus Ringnér, Karolina Holm, Cecilia Hegardt, Haukur Gunnarsson, Rainer Fagerholm, Carina Strand, Bjarni A Agnarsson, Outi Kilpivaara, Lena Luts, Päivi Heikkilä, Kristiina Aittomäki, Carl Blomqvist, Niklas Loman, Per Malmström, Håkan Olsson, Oskar Th Johannsson, Adalgeir Arason, Heli Nevanlinna, Rosa B Barkardottir, Åke Borg
The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells
Hirokuni Ikeda, Naruto Taira, Fumikata Hara, Takeo Fujita, Hiromasa Yamamoto, Junichi Soh, Shinichi Toyooka, Tomohiro Nogami, Tadahiko Shien, Hiroyoshi Doihara, Shinichiro Miyoshi
Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer
Cristina Cadenas, Dennis Franckenstein, Marcus Schmidt, Mathias Gehrmann, Matthias Hermes, Bettina Geppert, Wiebke Schormann, Lindsey J Maccoux, Markus Schug, Anika Schumann, Christian Wilhelm, Evgenia Freis, Katja Ickstadt, Jörg Rahnenführer, Jörg I Baumbach, Albert Sickmann, Jan G Hengstler